Review: Antibiotics Effectively Prevent Recurrent Cellulitis

This article originally appeared here.
Share this content:
Review: Antibiotics Effectively Prevent Recurrent Cellulitis
Review: Antibiotics Effectively Prevent Recurrent Cellulitis

MONDAY, Aug. 7, 2017 (HealthDay News) -- Antibiotic prophylaxis can prevent recurrence of cellulitis, according to a review published online June 20 in the Cochrane Library.

Adam Dalal, M.D., from Beilinson Hospital in Petah Tikva, Israel, and colleagues conducted a systematic literature review to assess the beneficial and adverse effects of antibiotic prophylaxis or other prophylactic interventions for prevention of recurrent episodes of cellulitis in six trials with 573 participants. Five trials assessed antibiotic prophylaxis in patients with cellulitis of the legs.

The researchers found that antibiotic prophylaxis correlated with reduced risk of recurrence compared with no treatment or placebo (risk ratio [RR], 0.31; 95 percent confidence interval [CI], 0.13 to 0.72) based on data from five trials. Compared with no treatment or placebo, antibiotic prophylaxis decreased the cellulitis incidence rate (RR, 0.44; 95 percent CI, 0.22 to 0.89) and significantly decreased the rate until the next episode of cellulitis (hazard ratio [HR], 0.51; 95 percent CI, 0.34 to 0.78). After prophylaxis had been stopped, the protective effects of antibiotics did not last for risk of cellulitis recurrence (RR, 0.88; 95 percent CI, 0.59 to 1.31), incidence rate of cellulitis (RR, 0.94; 95 percent CI, 0.65 to 1.36), or rate until next cellulitis episode (HR, 0.78; 95 percent CI, 0.39 to 1.56). There were no significant differences in adverse effects or hospitalization between antibiotic and no treatment or placebo.

"Larger, high-quality studies are warranted, including long-term follow-up and other prophylactic measures," the authors write.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions

More in Home

FDA Approves New Treatment for Acute Lymphoblastic Leukemia

FDA Approves New Treatment for Acute Lymphoblastic Leukemia

For patients with relapsed or refractory B-cell ALL who have received one or two prior treatments

Online Nursing Education Can Up Patient Use of VTE Prophylaxis

Online Nursing Education Can Up Patient Use of ...

Online training aims to make sure those hospitalized get treatment to prevent venous thromboembolism

On-Pump CABG Leads to Higher Rates of Five-Year Survival

On-Pump CABG Leads to Higher Rates of Five-Year ...

Study compared coronary-artery bypass grafting surgery, with/without cardiopulmonary bypass

is free, fast, and customized just for you!

Already a member?

Sign In Now »